Price
Target price
€21.50
€21.50
5.110%
1.07
5.110%
€33.55
23.04.24 / Tradegate
WKN: 529882 / Symbol: CORT / Name: Corcept / Stock / Pharmaceuticals / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Corcept Therapeutics Inc. Stock
A very strong showing by Corcept Therapeutics Inc. today, with an increase of €1.07 (5.110%) compared to yesterday's price.
Corcept Therapeutics Inc. is currently one of the favorites of our community with 9 Buy predictions and no Sell predictions.
As a result the target price of 33 € shows a very positive potential of 53.49% compared to the current price of 21.5 € for Corcept Therapeutics Inc..
Pros and Cons of Corcept Therapeutics Inc. in the next few years
Pros
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
G***** c******* t* c**********
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Corcept Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Corcept Therapeutics Inc. | 5.110% | -1.421% | -5.702% | 4.369% | -28.333% | 8.040% | - |
| Avid Bioservices Inc | 5.000% | -11.765% | -3.226% | -65.517% | -1.639% | -65.714% | 47.620% |
| Rockwell Medical Inc. | 1.620% | -4.810% | -3.193% | -26.923% | -20.034% | -85.152% | -96.854% |
| Gritstone Oncology Inc | -0.790% | -4.932% | -72.677% | -70.342% | -62.648% | -90.892% | - |
Comments
Corcept Therapeutics Incorporated (NASDAQ: CORT) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $38.00 price target on the stock.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) was downgraded by analysts at StockNews.com from a "strong-buy" rating to a "buy" rating.
Show more
Ratings data for CORT provided by MarketBeat
Corcept Therapeutics Incorporated (NASDAQ: CORT) was upgraded by analysts at StockNews.com from a "buy" rating to a "strong-buy" rating.
Show more
Ratings data for CORT provided by MarketBeat